-

Safety

  • Share Share this page

Combivent (ipratropium bromide and albuterol sulfate) Inhalation Aerosol

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- June 2009

 

Summary View

 

WARNINGS

Cardiovascular Effect
  • There is some evidence from post-marketing data and published literature of rare occurrences of myocardial ischemia associated with albuterol.
    
-
-
-
-
-